Hematopathology — MCQs
On this page
A 40-year-old female patient presents with excessive bleeding following a road traffic accident 5 hours prior, with a lacerated wound on the lower back. Blood grouping tests reveal the presence of Anti-A antibody, Anti-B antibody, Anti-H antibody, and Anti-Rh D antibody in her serum. What is the blood group of this patient?
Which of the following conditions typically shows an elevated Erythrocyte Sedimentation Rate (ESR)?
Bone marrow biopsy is useful in the diagnosis of which of the following conditions?
Bite cells are characteristic of which of the following conditions?
EBV positivity is higher in which type of Hodgkin lymphoma?
Primary hemostasis is disturbed in which of the following conditions?
Haemophilia is a genetic disorder of coagulation. It is transmitted as
FLT3-TKD gene is located at?
Spherocytosis of RBC is a common feature in which of the following conditions?
Which of the following is NOT a blood component product?
Hematopathology Indian Medical PG Practice Questions and MCQs
Question 1191: A 40-year-old female patient presents with excessive bleeding following a road traffic accident 5 hours prior, with a lacerated wound on the lower back. Blood grouping tests reveal the presence of Anti-A antibody, Anti-B antibody, Anti-H antibody, and Anti-Rh D antibody in her serum. What is the blood group of this patient?
- A. O positive
- B. O negative
- C. AB positive
- D. Bombay blood group (Correct Answer)
Explanation: **Explanation:** The correct answer is **Bombay blood group (Oh phenotype)**. **1. Why the Bombay blood group is correct:** The key to this question lies in the presence of **Anti-H antibodies**. In the ABO biosynthetic pathway, the **H substance** (formed by the action of fucosyltransferase on a precursor chain) is the essential substrate upon which A and B antigens are built. * Individuals with the **Bombay phenotype (hh)** lack the *H gene*; therefore, they cannot produce H substance. * Because they lack H substance, they cannot produce A or B antigens, even if they possess the A or B genes. * Consequently, their serum contains naturally occurring, potent, high-titer **Anti-A, Anti-B, and Anti-H antibodies** [1]. Since the patient also has Anti-Rh D, she is Rh-negative. **2. Why the other options are incorrect:** * **O Positive/Negative:** Individuals with blood group O possess the **H antigen** (in fact, they have the highest concentration of H substance). Therefore, they **do not** produce Anti-H antibodies. * **AB Positive:** These individuals have A, B, and H antigens on their RBCs; their serum contains no antibodies against these antigens [1]. **3. High-Yield Clinical Pearls for NEET-PG:** * **Discovery:** First described by Bhende in Mumbai (1952). * **Genotype:** *hh* (autosomal recessive inheritance). * **Testing Pitfall:** On routine forward grouping, Bombay blood group mimics **Group O** because it lacks A and B antigens. It is only identified during **reverse grouping** (cross-matching) because it reacts with O-group cells (due to Anti-H). * **Transfusion:** Patients can **only** receive blood from another Bombay phenotype individual. * **Secretor Status:** They are always non-secretors. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 627-628.
Question 1192: Which of the following conditions typically shows an elevated Erythrocyte Sedimentation Rate (ESR)?
- A. Multiple myeloma and Acute myocardial infarction (Correct Answer)
- B. Multiple myeloma
- C. Sickle cell anemia and Multiple myeloma
- D. Sickle cell anemia and Angina pectoris
Explanation: **Explanation:** The Erythrocyte Sedimentation Rate (ESR) is a non-specific marker of inflammation that measures the rate at which red blood cells (RBCs) settle in a vertical tube. The primary determinant of ESR is the formation of **Rouleaux** (stacking of RBCs), which is promoted by high-molecular-weight plasma proteins like **fibrinogen** and **immunoglobulins** [1]. 1. **Multiple Myeloma:** This plasma cell dyscrasia involves the overproduction of monoclonal immunoglobulins (M-protein). These positively charged proteins neutralize the negative surface charge (Zeta potential) of RBCs, leading to rapid Rouleaux formation and a characteristically **extremely high ESR** (often >100 mm/hr) [1]. 2. **Acute Myocardial Infarction (AMI):** AMI triggers an acute-phase response, leading to an increase in **fibrinogen** and other acute-phase reactants [2]. This causes the ESR to rise within 24–48 hours of the event. **Analysis of Incorrect Options:** * **Sickle Cell Anemia:** In this condition, the ESR is typically **low (near zero)**. The abnormally shaped (sickled) RBCs cannot stack into Rouleaux, hindering their ability to sediment. * **Angina Pectoris:** Unlike AMI, stable or unstable angina does not involve significant tissue necrosis or a systemic inflammatory response; therefore, the ESR remains **normal**. **High-Yield Clinical Pearls for NEET-PG:** * **Factors increasing ESR:** Pregnancy, old age, anemia (except sickle cell), macrocytosis, and malignancies. * **Factors decreasing ESR:** Polycythemia, spherocytosis, sickle cell anemia, and extreme leukocytosis. * **Key Distinction:** ESR is a lagging indicator; it rises slowly and stays elevated longer than **C-Reactive Protein (CRP)**, which responds rapidly to acute inflammation. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 607-608. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 580-581.
Question 1193: Bone marrow biopsy is useful in the diagnosis of which of the following conditions?
- A. Chronic Myeloid Leukemia (CML)
- B. Acute Lymphoblastic Leukemia (ALL)
- C. Aleukemic Leukemia (Correct Answer)
- D. Hodgkin's disease
Explanation: ### **Explanation** **Correct Answer: C. Aleukemic Leukemia** **Why Aleukemic Leukemia is the correct answer:** In **Aleukemic Leukemia**, the total white blood cell (WBC) count in the peripheral blood is either normal or decreased (leukopenia), and **no blast cells** are visible on a peripheral smear. However, the bone marrow is extensively infiltrated with malignant cells. Since the peripheral blood film (PBF) is non-diagnostic, a **bone marrow biopsy/aspiration** is mandatory to demonstrate the presence of blasts and confirm the diagnosis [1]. **Analysis of Incorrect Options:** * **A. Chronic Myeloid Leukemia (CML):** Diagnosis is primarily made via peripheral blood (marked leukocytosis with a full spectrum of myeloid cells) and confirmed by cytogenetics (Philadelphia chromosome). While marrow is hypercellular, it is not strictly required for the initial diagnosis. * **B. Acute Lymphoblastic Leukemia (ALL):** Most cases present with high WBC counts and circulating blasts. While a marrow study is done for classification, the diagnosis is often evident from the peripheral smear. * **D. Hodgkin’s Disease:** The primary diagnosis is made via **lymph node biopsy** (identifying Reed-Sternberg cells). Bone marrow biopsy is used for staging, not for the primary diagnosis. **NEET-PG High-Yield Pearls:** 1. **Subleukemic Leukemia:** Blasts are present in the peripheral blood, but the total WBC count is low/normal. 2. **Aleukemic Leukemia:** No blasts in peripheral blood + low/normal WBC count. 3. **Dry Tap:** Often encountered in Aleukemic Leukemia (due to packed marrow) or Myelofibrosis; this necessitates a **trephine biopsy** over aspiration [2]. 4. **Gold Standard:** Bone marrow biopsy is the gold standard for assessing **cellularity, storage disorders (Gaucher’s), and granulomas** [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 621-622. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 257-258.
Question 1194: Bite cells are characteristic of which of the following conditions?
- A. G6PD deficiency (Correct Answer)
- B. Thalassemia
- C. Hereditary spherocytosis
- D. Sideroblastic anemia
Explanation: **Explanation** **1. Why G6PD Deficiency is Correct:** Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency is an X-linked recessive disorder where the RBCs cannot handle oxidative stress [2]. In the absence of G6PD, reduced glutathione is not regenerated, leading to the oxidation of hemoglobin. This oxidized hemoglobin precipitates to form **Heinz bodies**. As these RBCs pass through the splenic sinusoids, splenic macrophages "pluck out" these inclusions [1]. The resulting RBC with a semi-circular defect in its margin is called a **Bite cell (Degmacyte)** [1]. If the cell undergoes further remodeling, it may become a **Blister cell**. **2. Why the Other Options are Incorrect:** * **Thalassemia:** Characterized by **Target cells** (codocytes) and microcytic hypochromic anemia due to globin chain synthesis defects. Basophilic stippling is also common. * **Hereditary Spherocytosis:** Characterized by **Spherocytes** (small, dark RBCs lacking central pallor) due to defects in membrane proteins like Ankyrin or Spectrin. * **Sideroblastic Anemia:** Characterized by **Ring sideroblasts** in the bone marrow (iron-laden mitochondria surrounding the nucleus) and Pappenheimer bodies in peripheral blood. **3. NEET-PG High-Yield Pearls:** * **Heinz Bodies:** Visible only with **Supravital stains** (e.g., Crystal Violet or New Methylene Blue); they are not seen on routine Leishman/Giemsa stains. * **Triggers:** Oxidative stress induced by Fava beans, infections, or drugs (Primaquine, Sulphonamides, Dapsone). * **Inheritance:** X-linked recessive (more common in males) [2]. * **Protective Effect:** G6PD deficiency provides a survival advantage against *Plasmodium falciparum* malaria. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 642-643. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 652-654.
Question 1195: EBV positivity is higher in which type of Hodgkin lymphoma?
- A. Nodular sclerosis
- B. Mixed cellularity (Correct Answer)
- C. Lymphocyte depleted
- D. Lymphocyte rich
Explanation: **Explanation:** The association between **Epstein-Barr Virus (EBV)** and Hodgkin Lymphoma (HL) varies significantly across histological subtypes. EBV is found in the Reed-Sternberg (RS) cells, where it expresses LMP-1 (Latent Membrane Protein-1), mimicking CD40 signaling to promote B-cell survival. * **Mixed Cellularity (MC):** This subtype shows the strongest association with EBV in classical HL, with **75% to 85%** of cases being EBV-positive. It typically affects older patients or those in developing countries and is characterized by a polymorphic inflammatory infiltrate (eosinophils, plasma cells, histiocytes) [1]. * **Lymphocyte Depleted (LD):** This also has a very high association with EBV (approx. 90%), but it is the rarest subtype. In the context of standard NEET-PG questions, **Mixed Cellularity** is the classic answer for "highest association" among the common subtypes [1]. * **Nodular Sclerosis (NS):** This is the most common subtype overall (especially in young females). It has a relatively low EBV association (approx. 10-40%) [1]. * **Lymphocyte Rich (LR):** This subtype has an intermediate association (approx. 40%) and carries a very good prognosis [1]. * **Nodular Lymphocyte Predominant HL (NLPHL):** This is a non-classical HL and is almost **always EBV-negative**. **High-Yield Pearls for NEET-PG:** 1. **Most common subtype:** Nodular Sclerosis (characterized by Lacunar cells and collagen bands) [1]. 2. **Best prognosis:** Lymphocyte Rich (among classical) or NLPHL. 3. **Worst prognosis:** Lymphocyte Depleted. 4. **RS Cell Markers:** Classical HL is **CD15+, CD30+, and CD45–**. NLPHL is **CD20+ and CD45+** (Popcorn cells). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 616-618.
Question 1196: Primary hemostasis is disturbed in which of the following conditions?
- A. Platelet disorder (Correct Answer)
- B. Lupus anticoagulant
- C. Hemophilia
- D. Liver disease
Explanation: **Explanation:** Hemostasis is divided into two main stages: **Primary hemostasis**, which involves the formation of a platelet plug, and **Secondary hemostasis**, which involves the activation of the coagulation cascade to form a stable fibrin clot [1], [3]. **Why Option A is Correct:** Primary hemostasis depends on the interaction between the blood vessel wall, von Willebrand factor (vWF), and platelets [4]. Therefore, any **Platelet disorder**—whether quantitative (Thrombocytopenia) or qualitative (e.g., Bernard-Soulier Syndrome, Glanzmann Thrombasthenia)—directly impairs the formation of the initial platelet plug [1], [2]. Clinical markers of primary hemostatic defects include petechiae, purpura, and mucosal bleeding (epistaxis, gum bleeding) [5]. **Why Other Options are Incorrect:** * **B. Lupus anticoagulant:** This is an antiphospholipid antibody. While it paradoxically prolongs clotting times *in vitro*, it is clinically associated with a prothrombotic state (thrombosis) rather than a primary bleeding defect. * **C. Hemophilia:** Hemophilia A (Factor VIII deficiency) and B (Factor IX deficiency) are disorders of **secondary hemostasis** [5]. Patients have normal platelet plugs but cannot stabilize them with fibrin, leading to deep-seated bleeds like hemarthrosis and muscle hematomas [5]. * **D. Liver disease:** While liver disease can affect platelets (via hypersplenism), it primarily causes a complex defect in **secondary hemostasis** due to the decreased synthesis of almost all coagulation factors (except Factor VIII and vWF). **High-Yield Clinical Pearls for NEET-PG:** * **Screening Test:** Bleeding Time (BT) is the classic (though now less used) marker for primary hemostasis; PT and aPTT assess secondary hemostasis. * **vWF Disease:** This is unique because it affects **both** primary hemostasis (vWF is needed for platelet adhesion) and secondary hemostasis (vWF stabilizes Factor VIII). * **Platelet Morphology:** Giant platelets are seen in Bernard-Soulier Syndrome; absent granules are seen in Gray Platelet Syndrome [2]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 619-620. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 668-669. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 581-582. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, p. 128. [5] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, p. 132.
Question 1197: Haemophilia is a genetic disorder of coagulation. It is transmitted as
- A. X-linked dormant
- B. Y-linked dormant
- C. X-linked recessive (Correct Answer)
- D. Autosomal recessive
Explanation: **Explanation:** **Haemophilia (A and B)** is a classic example of an **X-linked recessive** inheritance pattern [1]. 1. **Why X-linked Recessive is correct:** The genes for Factor VIII (Haemophilia A) and Factor IX (Haemophilia B) are located on the **X chromosome**. Because it is recessive, males (XY) are primarily affected as they possess only one X chromosome (hemizygous) [1]. Females (XX) are typically asymptomatic carriers because their second X chromosome usually carries a functional gene that provides sufficient clotting factor levels. 2. **Why other options are incorrect:** * **X-linked dormant:** "Dormant" is not a standard genetic term for inheritance. The correct term for a trait that is expressed only when no dominant allele is present is "recessive." * **Y-linked:** Y-linked (holandric) traits are passed only from father to son [1]. Haemophilia genes are not located on the Y chromosome. * **Autosomal recessive:** This would imply the gene is on a non-sex chromosome (1-22). While rare bleeding disorders like Factor X deficiency are autosomal, Haemophilia A and B are strictly sex-linked. **High-Yield Clinical Pearls for NEET-PG:** * **Lyonization:** Female carriers may occasionally show bleeding tendencies due to "unfavorable lyonization" (random inactivation of the X chromosome carrying the normal gene) [2]. * **Inheritance Pattern:** An affected father will pass the gene to **all** his daughters (carriers) but **none** of his sons [1]. * **Clinical Presentation:** Characterized by **hemarthrosis** (bleeding into joints) and delayed bleeding after trauma. * **Laboratory:** Prolonged **aPTT** with a normal PT and normal bleeding time. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, p. 151. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 670-671.
Question 1198: FLT3-TKD gene is located at?
- A. 13q12 (Correct Answer)
- B. 11q23
- C. 11p13
- D. 4q24
Explanation: ### Explanation **Correct Option: A (13q12)** The **FLT3** (*Fms-like tyrosine kinase 3*) gene is located on the long arm of **chromosome 13 (13q12)**. It encodes a Class III receptor tyrosine kinase essential for the proliferation and survival of hematopoietic stem cells [1]. In Acute Myeloid Leukemia (AML), FLT3 mutations are highly significant: 1. **FLT3-ITD (Internal Tandem Duplication):** Most common; associated with a **poor prognosis**, high relapse rates, and high leukocytosis [1]. 2. **FLT3-TKD (Tyrosine Kinase Domain):** Point mutations (usually at codon D835) that lead to constitutive activation of the kinase [1]. **Analysis of Incorrect Options:** * **B. 11q23:** This is the locus for the **KMT2A (formerly MLL)** gene. Rearrangements here are common in infant leukemias and therapy-related AML (topoisomerase II inhibitor-induced). * **C. 11p13:** This is the locus for the **WT1** (Wilms Tumor 1) gene. Mutations are seen in Wilms tumor and a subset of AML cases. * **D. 4q24:** This is the locus for the **TET2** gene, frequently mutated in myelodysplastic syndromes (MDS) and AML, affecting DNA methylation. **High-Yield Clinical Pearls for NEET-PG:** * **Most common mutation in AML:** FLT3 (found in ~30% of cases). * **Prognostic Significance:** FLT3-ITD mutations confer a worse prognosis compared to FLT3-TKD. * **Targeted Therapy:** Midostaurin and Gilteritinib are FLT3 inhibitors used in treatment. * **NPM1 vs. FLT3:** In the absence of FLT3-ITD, an *NPM1* mutation signifies a favorable prognosis in cytogenetically normal AML. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 620-621.
Question 1199: Spherocytosis of RBC is a common feature in which of the following conditions?
- A. G6PD deficiency (Correct Answer)
- B. Sickle cell anemia
- C. CML
- D. All of the above
Explanation: ### Explanation **Correct Option: A (G6PD deficiency)** In G6PD deficiency, oxidative stress leads to the denaturation of hemoglobin, forming **Heinz bodies**. As these RBCs pass through the splenic sinusoids, splenic macrophages "pluck out" these inclusions [1]. This process, known as **"pitting,"** results in a loss of the erythrocyte cell membrane. The reduced surface-area-to-volume ratio forces the cell to assume a spherical shape (**Spherocytes**) [1]. While "Bite cells" (degmacytes) are the classic hallmark, spherocytes are a frequent and significant finding during an acute hemolytic episode [1]. **Incorrect Options:** * **B. Sickle Cell Anemia:** The hallmark finding is **Sickle cells (drepanocytes)** and target cells. While extravascular hemolysis occurs, the primary morphology is driven by HbS polymerization under deoxygenated conditions, not membrane loss leading to spherocytosis. * **C. CML (Chronic Myeloid Leukemia):** This is a myeloproliferative neoplasm characterized by a "leukemic hiatus" (presence of all stages of granulocyte maturation) and a hypercellular marrow. RBC morphology is typically normocytic normochromic, though **Dacrocytes (teardrop cells)** may be seen if myelofibrosis develops. **High-Yield Clinical Pearls for NEET-PG:** * **Differential Diagnosis of Spherocytes:** 1. **Hereditary Spherocytosis:** Due to defects in membrane proteins (Ankyrin is most common) [3]. 2. **Autoimmune Hemolytic Anemia (AIHA):** The most common cause of *acquired* spherocytosis [2]. 3. **G6PD Deficiency:** Occurs after the formation of Heinz bodies [1]. * **Key Distinction:** Spherocytes in Hereditary Spherocytosis have a negative Coombs test, whereas those in AIHA have a positive Coombs test [2]. * **G6PD Staining:** Heinz bodies are not visible on Romanowsky stains (like Leishman); they require **supravital stains** (e.g., Crystal Violet or Methyl Violet). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 642-643. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 602-603. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 640-641.
Question 1200: Which of the following is NOT a blood component product?
- A. Whole blood
- B. Platelets
- C. Lymphoma
- D. None of the above (Correct Answer)
Explanation: ### Explanation The core concept behind this question is the distinction between **blood components** and **blood derivatives**. Blood components are parts of whole blood separated by simple physical means (like centrifugation), while blood derivatives are products manufactured from pooled plasma using pharmaceutical processes. [1] **Why "None of the above" is the correct answer:** The question asks which of the options is **NOT** a blood component. However, all the listed options (Whole blood and Platelets) are standard blood components. Since there is no option provided that qualifies as a non-component (like Albumin or Factor VIII concentrate), "None of the above" is the logically correct choice. **Analysis of Options:** * **Whole Blood:** This is the basic unit collected from a donor. It is the primary source from which all other components are derived and is itself considered a blood component. * **Platelets:** These are separated from whole blood via centrifugation (Random Donor Platelets) or collected via apheresis (Single Donor Platelets). [1] They are a vital cellular component used to treat thrombocytopenia. [1] * **Lymphoma (Note on Option C):** In the context of this specific question structure, if "Lymphoma" is listed as an option, it is a pathological condition (malignancy of lymphoid tissue) and not a blood product. However, based on the provided key where "None of the above" is marked correct, it implies that the options provided are intended to be valid components. **High-Yield Clinical Pearls for NEET-PG:** * **Blood Components:** Include Whole Blood, Packed Red Blood Cells (PRBC), Fresh Frozen Plasma (FFP), Platelets, and Cryoprecipitate. * **Blood Derivatives:** Include Albumin, Immunoglobulins, and Coagulation Factor concentrates. * **Storage Temperatures:** * PRBC: 2–6°C * Platelets: 20–24°C (with constant agitation) * FFP/Cryoprecipitate: -18°C or colder. * **Shelf Life:** Platelets have the shortest shelf life (5 days) due to the risk of bacterial contamination at room temperature. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 581-582.
Practice by Chapter
Anemias: Classification and Approach
Practice Questions
Hemolytic Anemias
Practice Questions
Myeloproliferative Neoplasms
Practice Questions
Myelodysplastic Syndromes
Practice Questions
Acute Leukemias
Practice Questions
Chronic Leukemias
Practice Questions
Lymphomas and Lymphoid Neoplasms
Practice Questions
Plasma Cell Disorders
Practice Questions
Bleeding Disorders
Practice Questions
Thrombotic Disorders
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free